Strategic Advisors LLC Gilead Sciences, Inc. Transaction History

Strategic Advisors LLC

$509 Million
Q2 2024

A detailed history of Strategic Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Strategic Advisors LLC holds 10,700 shares of GILD stock, worth $906,718. This represents 0.14% of its overall portfolio holdings.

Number of Shares

10,700

Previous 10,700 -0.0%

Holding current value

$906,718

Previous $783,000 6.26%

% of portfolio

0.14%

Previous 0.16%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	SELL	$71.58 - $87.29 $2,648 - $3,229	-37 Reduced 0.34%	10,700 $783,000
Q4 2023 Jan 19, 2024	BUY	$73.27 - $83.09 $2,710 - $3,074	37 Added 0.35%	10,737 $869,000
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $666,824 - $957,329	10,700 New	10,700 $0
Q1 2021 May 05, 2021	SELL	$60.0 - $68.46 $205,860 - $234,886	-3,431 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $151,198 - $172,283	-2,669 Reduced 43.75%	3,431 $214,000
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $43,470 - $54,656	-700 Reduced 10.29%	6,100 $387,000
Q2 2020 Aug 12, 2020	BUY	$72.34 - $84.0 $217,020 - $252,000	3,000 Added 78.95%	6,800 $518,000
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $18,486 - $20,334	-300 Reduced 7.32%	3,800 $247,000
Q3 2019 Oct 17, 2019	SELL	$62.51 - $69.0 $66,198 - $73,071	-1,059 Reduced 20.53%	4,100 $260,000
Q2 2019 Jul 22, 2019	SELL	$61.87 - $69.38 $109,509 - $122,802	-1,770 Reduced 25.54%	5,159 $348,000
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $36,830 - $41,259	-589 Reduced 7.83%	6,929 $450,000
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $181,075 - $236,289	-2,991 Reduced 28.46%	7,518 $470,000
Q3 2018 Oct 18, 2018	SELL	$71.28 - $78.92 $38,990 - $43,169	-547 Reduced 4.95%	10,509 $811,000
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $18,425 - $21,493	-284 Reduced 2.5%	11,056 $783,000
Q1 2018 Apr 19, 2018	SELL	$72.84 - $88.8 $22,871 - $27,883	-314 Reduced 2.69%	11,340 $855,000
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $113,270 - $132,963	-1,592 Reduced 12.02%	11,654 $835,000
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $6,994 - $8,290	97 Added 0.74%	13,246 $1.07 Million
Q2 2017 Aug 10, 2017	BUY	N/A	13,149	13,149 $931,000

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advisors LLC with notifications on news.

Account

Strategic Advisors LLC Gilead Sciences, Inc. Transaction History